Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201307074 Principal Investigator: Stockerl-Goldstein, Keith
Title: A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician’s Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Phase: III Disease Site: Other Hematopoietic
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if MLN9708 plus dexamethasone works against systemic light chain amyloidosis better than the physician’s choice chemotherapy treatment.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)